Christopher Chang Selected Research

Christopher Chang Research Topics

Disease

25	Autoimmune Diseases (Autoimmune Disease) 02/2021 - 10/2002
10	Hypersensitivity (Allergy) 02/2022 - 12/2004
9	Infections 01/2020 - 10/2002
7	Neoplasms (Cancer) 01/2020 - 05/2010
7	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2020 - 05/2011
7	Asthma (Bronchial Asthma) 08/2019 - 12/2004
7	Irritable Bowel Syndrome (Syndrome, Irritable Bowel) 01/2018 - 09/2011
6	Inflammation (Inflammations) 04/2017 - 08/2012
5	Food Hypersensitivity (Food Allergy) 01/2020 - 06/2014
4	COVID-19 01/2022 - 01/2020
4	Rheumatoid Arthritis 10/2020 - 02/2017
4	Osteonecrosis (Kienbock's Disease) 01/2020 - 10/2002
4	Biliary Liver Cirrhosis (Primary Biliary Cirrhosis) 01/2020 - 08/2014
4	Atopic Dermatitis (Atopic Eczema) 12/2016 - 06/2014
4	Genetic Predisposition to Disease (Genetic Predisposition) 08/2014 - 04/2011
4	Constipation 06/2014 - 06/2011
3	Psoriasis (Pustulosis Palmaris et Plantaris) 02/2017 - 04/2016
2	Skin Diseases (Skin Disease) 12/2022 - 12/2021
2	Necrosis 01/2022 - 05/2011
2	Wounds and Injuries (Trauma) 01/2022 - 09/2010
2	Pain (Aches) 01/2022 - 03/2019
2	Contact Dermatitis (Eczema, Contact) 12/2021 - 07/2021
2	Carcinogenesis 01/2021 - 08/2015
2	Dermatomyositis (Dermatopolymyositis) 10/2020 - 05/2012
2	Liver Diseases (Liver Disease) 04/2020 - 03/2015
2	Autoimmune Hepatitis 04/2020 - 07/2019
2	Multiple Sclerosis 01/2020 - 02/2017
2	Diarrhea 01/2018 - 01/2015
2	Disease Progression 09/2017 - 07/2011
2	Gastroenteritis 05/2015 - 01/2015
2	Immediate Hypersensitivity 08/2014 - 06/2014
2	Anaphylaxis (Anaphylactic Shock) 08/2014 - 01/2012
2	Eosinophilic Esophagitis 06/2014 - 06/2014
2	Enterocolitis 06/2014 - 06/2014
2	Rheumatic Fever (Acute Articular Rheumatism) 04/2014 - 04/2012
1	Pneumoperitoneum 01/2022
1	Gallbladder Diseases (Gall Bladder Disease) 01/2022
1	Delayed Hypersensitivity (Hypersensitivity, Type IV) 12/2021
1	Dermatitis 12/2021
1	Tertiary Lymphoid Structures 02/2021
1	Melanoma (Melanoma, Malignant) 01/2021
1	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 10/2020
1	Systemic Scleroderma (Systemic Sclerosis) 10/2020
1	Hemorrhage 07/2020
1	Osteoarthritis 07/2020

Drug/Important Bio-Agent (IBA)

18	AutoantibodiesIBA 02/2021 - 05/2010
15	CytokinesIBA 01/2022 - 03/2013
8	Pharmaceutical PreparationsIBA 02/2022 - 05/2010
8	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2020 - 10/2002
7	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2014
7	Biomarkers (Surrogate Marker)IBA 01/2017 - 07/2011
6	Biological ProductsIBA 01/2022 - 05/2010
6	VaccinesIBA 01/2020 - 04/2012
6	Anti-Bacterial Agents (Antibiotics)IBA 06/2014 - 06/2011
5	AllergensIBA 12/2021 - 12/2004
5	MicroRNAs (MicroRNA)IBA 01/2020 - 10/2014
5	SteroidsIBA 01/2020 - 10/2002
5	Immunoglobulin E (IgE)IBA 01/2020 - 01/2012
5	AntibodiesIBA 07/2019 - 05/2012
4	cytolethal distending toxinIBA 05/2015 - 09/2011
3	InterferonsIBA 01/2021 - 05/2011
3	Immunoglobulin G (IgG)IBA 07/2019 - 02/2014
3	Histones (Histone)IBA 01/2017 - 10/2014
3	Vitamin D FDA LinkGeneric 12/2016 - 06/2014
3	AutoantigensIBA 06/2016 - 07/2011
3	ChemokinesIBA 06/2016 - 12/2013
2	InflammasomesIBA 01/2021 - 01/2014
2	Transcription Factors (Transcription Factor)IBA 10/2020 - 01/2019
2	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 07/2020 - 01/2012
2	Intravenous Immunoglobulins (IVIG)FDA Link 01/2020 - 03/2019
2	ProstaglandinsIBA 11/2018 - 02/2015
2	Immunoglobulin M (IgM)IBA 01/2018 - 02/2014
2	CD40 Ligand (CD40L)IBA 01/2018 - 02/2014
2	Rifaximin (L 105)FDA Link 01/2018 - 06/2014
2	Interleukin-1 (Interleukin 1)IBA 12/2016 - 01/2014
2	Filaggrin ProteinsIBA 12/2016 - 02/2015
2	CalciumIBA 11/2015 - 08/2011
2	VinculinIBA 05/2015 - 01/2015
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 12/2022
1	Materia Medica (Homeopathic Remedies)IBA 02/2022
1	Carbon DioxideIBA 01/2022
1	Volatile Organic CompoundsIBA 01/2022
1	SmokeIBA 01/2022
1	RNA (Ribonucleic Acid)IBA 02/2021
1	Interleukin-6 (Interleukin 6)IBA 01/2021
1	InterleukinsIBA 01/2021
1	Interferon Type IIBA 10/2020
1	Fibric Acids (Fibrates)IBA 04/2020
1	Immunosuppressive Agents (Immunosuppressants)IBA 04/2020

Therapy/Procedure

14	Therapeutics 01/2022 - 09/2010
5	Immunotherapy 08/2019 - 12/2004
2	Artificial Respiration (Mechanical Ventilation) 01/2020 - 02/2015
2	Aftercare (After-Treatment) 06/2014 - 01/2014
2	Drug Therapy (Chemotherapy) 01/2014 - 05/2010
2	Length of Stay 08/2012 - 11/2006
1	Laparoscopic Cholecystectomy 01/2022
1	Minimally Invasive Surgical Procedures 01/2022
1	Meditation 01/2022
1	Physical Therapy Modalities (Physical Therapy Technique) 01/2022
1	Cholecystectomy 01/2022